(Press-News.org) BOSTON – Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment. Some studies have looked at replacing RGCs through cell transplants, but this process is still in the research and development stage and fraught with limitations that highlight a need for a more precise manner of effectively repopulating these cells in the retina. Now, a multidisciplinary team led by researchers at the Schepens Eye Research Institute of Mass Eye and Ear has identified a promising new strategy for glaucoma cell replacement therapy.
In their new study, researchers changed the microenvironment in the eye in a way that enabled them to take stem cells from blood and turn them into retinal ganglion cells that were capable of migrating and surviving into the eye’s retina. They conducted their study on the adult mouse retina, but the work’s implications could one day be applied to human retina, according to the researchers who published their findings November 6th in Proceedings of the National Academy of Sciences of the United States of America (PNAS).
One limitation that prevents the success of current stem cell transplantation strategies in retina studies is that the majority of donor cells remain at the site of injection and do not migrate where they are most needed. To identify an improved solution, the researchers created RGCs out of stem cells, then tested the ability of various signaling molecules known as chemokines to guide these new neurons to their correct positions within the retina. The research team utilized a “big data” approach and examined hundreds of such molecules and receptors to find 12 unique to RGCs. They found stromal derived factor 1 was the best performing molecule for both migration and transplantation.
“This method of using chemokines to guide donor cell movement and integration represents a promising approach to restoring vision in glaucoma patients,” said senior author Petr Baranov, MD, PhD, of Mass Eye and Ear, who is also an assistant professor of Ophthalmology at Harvard Medical School. “It was an exciting journey to work with a team of talented scientists with unique expertise to develop novel techniques in this study to modify the local environment to guide cell behavior – techniques that potentially be applied to treat other neurodegenerative conditions.”
The study was co-led by members of Baranov’s lab at Mass Eye and Ear including bioengineer and lead study author Jonathan R Soucy, PhD, and lead bioinformatician Emil Kriukov, MD.
In addition to Baranov, Soucy and Kriukov, co-authors of the study include Levi Todd, Monichan Phay, Volha V. Malechka, John Dayron Rivera and Thomas A Reh.
The study was funded by several National Eye Institute (NEI) of the National Institutes of Health (NIH) grants – a complete list can be found in the paper – and grants from the Bright Focus Foundation and Gilbert Family Foundation.
The University of Washington discloses a patent incorporating the endogenous reprogramming technology described in this report with inventors LT and TAR.
in Proceedings of the National Academy of Sciences of the United States of America.
About Mass Eye and Ear
Massachusetts Eye and Ear, founded in 1824, is an international center for treatment and research and a teaching hospital of Harvard Medical School. A member of Mass General Brigham, Mass Eye and Ear specializes in ophthalmology (eye care) and otolaryngology–head and neck surgery (ear, nose and throat care). Mass Eye and Ear clinicians provide care ranging from the routine to the very complex. Also home to the world's largest community of hearing and vision researchers, Mass Eye and Ear scientists are driven by a mission to discover the basic biology underlying conditions affecting the eyes, ears, nose, throat, head and neck and to develop new treatments and cures. In the 2023–2024 “Best Hospitals Survey,” U.S. News & World Report ranked Mass Eye and Ear #4 in the nation for eye care and #7 for ear, nose and throat care. For more information about life-changing care and research at Mass Eye and Ear, visit our blog, Focus, and follow us on Instagram, Twitter and Facebook.
Mass Eye and Ear researchers develop potential glaucoma treatment strategy to guide stem cells to the retina
ELSE PRESS RELEASES FROM THIS DATE:
RIT researcher receives NIH funding to help design better drugs
Rochester Institute of Technology’s Emiliano Brini, assistant professor in the School of Chemistry and Materials Science, has received an award from the National Institutes of Health (NIH) to support his research on building the next generation of drugs. Brini and his team of students will develop computational tools that can predict the strength of the interaction between two proteins and how drugs will modify this interaction. Physics-based methodologies will quickly and accurately provide such predictions. Designing a new ...
UChicago’s Pritzker School of Molecular Engineering Faculty boost vaccines and immunotherapies with machine learning to drive more effective treatments
Small molecules called immunomodulators can help create more effective vaccines and stronger immunotherapies to treat cancer. But finding the molecules that instigate the right immune response is difficult —the number of drug-like small molecules has been estimated to be 1060, much higher than the number of stars in the visible universe. In a potential first for the field of vaccine design, machine learning guided the discovery of new immune pathway-enhancing molecules and found one particular small molecule that could outperform the best immunomodulators on the market. The ...
Seven ORNL scientists among world’s top 1% most-cited researchers
Seven scientists from the Department of Energy’s Oak Ridge National Laboratory have been named among the world’s most influential researchers on the 2023 Highly Cited Researchers list, produced by Clarivate, a data analytics firm that specializes in scientific and academic research. "These scientists have delivered significant impact for the scientific community and nation," said ORNL Director Stephen Streiffer. "This honor highlights their commitment, hard work and leadership in their respective fields.” The ORNL researchers named to the list are: Miaofang Chi, Center for Nanophase Materials Sciences David A. Cullen, Center for Nanophase Materials ...
Lung cancer cells’ ‘memories’ suggest new strategy for improving treatment
A new understanding of lung cancer cells’ “memories” suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found. Research from the lab of cancer biologist Tuomas Tammela, MD, PhD shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective. The study looked specifically at lung adenocarcinoma, a type of non-small ...
Idai vs. Impalas: New study shows in real-time what helps mammals survive a natural disaster
When Cyclone Idai swept through Mozambique’s Gorongosa National Park in May 2019, one of nature‘s deadliest forces encountered one of the most technologically sophisticated wildlife parks on the planet. Princeton researchers and colleagues from around the world documented the effects using trail cameras and animal-tracking devices that had been in use before the storm. Thanks to the extensive network of cameras, GPS collars and other instruments, park staff and ...
Nanoplastics promote conditions for Parkinson’s across various lab models
DURHAM, N.C. – Nanoplastics interact with a particular protein that is naturally found in the brain, creating changes linked to Parkinson’s disease and some types of dementia. In a Duke-led study appearing Nov. 17 in Science Advances, the researchers report that the findings create a foundation for a new area of investigation, fueled by the timely impact of environmental factors on human biology. “Parkinson’s disease has been called the fastest growing neurological disorder in the world,” said principal investigator, Andrew West, Ph.D., professor in the Department of Pharmacology and Cancer Biology at ...
New research suggests plants might be able to absorb more CO2 from human activities than previously expected
New research published today in leading international journal Science Advances paints an uncharacteristically upbeat picture for the planet. This is because more realistic ecological modelling suggests the world’s plants may be able to take up more atmospheric CO2 from human activities than previously predicted. Despite this headline finding, the environmental scientists behind the research are quick to underline that this should in no way be taken to mean the world’s governments can take their foot off the brake in their obligations to reduce carbon ...
In the fight against malaria-carrying mosquitoes, just add soap
EL PASO, Texas (Nov. 17, 2023) – Could the solution to the decades-long battle against malaria be as simple as soap? In a new study published in PLOS Neglected Tropical Diseases, scientists at The University of Texas at El Paso have made a compelling case for it. The team has found that adding small quantities of liquid soap to some classes of pesticides can boost their potency by more than ten-fold. The discovery is promising news as malaria-carrying mosquitoes display ...
Deep dive on sea level rise: new modelling gives better predictions on Antarctic ice sheet melt
Using historical records from around Australia, an international team of researchers have put forward the most accurate prediction to date of past Antarctic ice sheet melt, providing a more realistic forecast of future sea level rise. The Antarctic ice sheet is the largest block of ice on earth, containing over 30 million cubic kilometers of water. Hence, its melting could have a devasting impact on future sea levels. To find out just how big that impact might be, the research team, including Dr Mark Hoggard from The Australian National University, turned to the past. “If ...
Crime-free housing policies increase evictions among minorities, but do not cut crime
Policies that encourage landlords to evict tenants who have involvement with the criminal justice system do not appear to reduce crime, while increasing evictions among Black residents and people with lower incomes, according to a new RAND Corporation report. Studying “crime-free housing policies” adopted by cities in California over a decade-long period, researchers found no meaningful statistical evidence that the policies reduce crime. The study also found that crime-free housing policies significantly increased ...